logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
侯鹏 封面图

侯鹏 (Peng Hou)

international joint research center for tumor precision medicine of shaanxi province

45H指数
222论文数
7.4K被引数
收录论文 110
发表时间
logo
Disrupting KRAS–AGO2 interaction: a dual-pronged strategy to sensitize chemo-immunotherapy in KRAS-mutated colorectal cancer破坏KRAS–AGO2相互作用：一种双重策略以增强KRAS突变结直肠癌的化免联合疗法敏感性
errApoptosis
IF8.1
err2026-08-20
err0
PREAI
errJingyi Xie; Simeng Wang; Juan Liu; Yan Zhang; Haixiao Zhu; Rongrong Cui; Yao Yao; Wei Yu; Peng Hou
err分享
err收藏
Power Collection System Optimization for Floating Offshore Wind Farms Combined with Oil and Gas Platforms Considering Wake Effect浮式海上风电场与油气平台结合的功率收集系统优化，考虑尾流效应
errEnergies
IF3.2
err2026-04-23
err0
errOAAI
errTongyu Wang; Peng Hou; Rongsen Jin
err分享
err收藏
TRMT6-Mediated m1A Modification of CDK9 mRNA Is a Dual-Pronged Pathogenic Driver for HBV-Related Hepatocellular CarcinomaTRMT6介导的CDK9 mRNA中m1A修饰是HBV相关肝细胞癌的双刃剑致病驱动因素
errAdvanced Science
IF14.1
err2026-04-20
err0
errOAAI
errRui Zhang; Dandan Zong; Rui Liu; Yubo Wang; Qingqing Gu; Yao Yao; Wenfang Zheng; Mengmeng Yuan; Simeng Wang; Rongrong Cui; Daxu Li; Siwen Dang; Peng Hou
err分享
err收藏
Targeting DDOST improves the efficacy of lenvatinib and immunotherapy in hepatocellular carcinoma靶向DDOST可提高仑伐替尼和免疫疗法在肝细胞癌中的疗效
errExperimental & Molecular Medicine
IF0
err2025-12-19
err0
errOAAI
errJun Pu; Jingjing Ma; Yan Liu; Rongrong Cui; Yao Yao; Guanjun Zhang; Peng Hou; Xi Liu; Qi Yang; Meiju Ji
err分享
err收藏
Low-normal free thyroxine is associated with a higher prevalence of lower extremity arterial disease in euthyroid type 2 diabetes mellitus低正常游离甲状腺素与甲状腺功能正常型2型糖尿病中下肢动脉疾病的更高患病率相关
errScientific Reports
IF3.9
err2025-12-09
err0
errOAAI
errMin Zhang; Chenwen Luo; Jianling Wang; Jieying Wang; Banjun Ruan; Peng Hou; Pu Chen
err分享
err收藏
TET1 loss propels the development of hyperthyroidism by remodeling histone modifications of PAX8 promoterTET1缺失通过重塑PAX8启动子的组蛋白修饰，推动甲状腺功能亢进症的发展。
errExperimental & Molecular Medicine
IF12.9
err2025-10-29
err0
errOAAI
errHui Dang; Yan Liu; Ye Zhou; Mengjun Sui; Yubo Wang; Wei Qiang; Fang Sui; Yan Zhang; Hongxin Cao; Xiaoyan Wu; Meiju Ji; Peng Hou
err分享
err收藏
Penfluridol enhances anti-tumor immunity in colorectal cancer by inducing proteasome-mediated degradation of PD-L1 via the activation of AMPKPenfluridol通过激活AMPK诱导蛋白酶体介导的PD-L1降解，从而增强结直肠癌的抗肿瘤免疫。
errTranslational Oncology
IF4.1
err2025-10-03
err0
errOAAI
errJianling Wang; Yan Zhang; Quan Chen; Xiaorui Wang; Rongrong Cui; Peng Hou
err分享
err收藏
ARID1A Governs Genomic Stability and Proliferation in SCLC via c-MYC/PARP1 Suppression Driving Vulnerability to BET InhibitorsARID1A通过抑制c-MYC/PARP1调控基因组稳定性和增殖，并驱动小细胞肺癌对BET抑制剂的易感性。
errResearch
IF10.7
err2025-10-02
err0
errOAAI
errGuozhen Cao; Liying Ma; Xueqin Dai; Peng Hou; Xinhuang Yao; Gongfeng Li; Jiahui Zhang; Ceshi Chen; Wenchu Lin
err分享
err收藏
ZFP36 reverses chemoresistance by disrupting lipid droplets accumulation in non-small cell lung cancerZFP36通过破坏脂滴积累来逆转非小细胞肺癌的化疗耐药性
errCellular Signalling
IF3.7
err2025-09-12
err0
PREAI
errZhe Wang; Peng Hou; Yang Wu; Jiaojiao Dai; Ping Zhao; Xiaoxun Cheng; Zhengze Hu; Lingling Zhang; Jinghan Hua
err分享
err收藏
Compression of big data collected in wind farm based on tensor train decomposition基于张量列分解的风电场大数据压缩
errBig Data Research
IF4.2
err2025-08-20
err0
PREAI
errKeren Li; Wenqiang Zhang; Dandan Xiao; Peng Hou; Shuai Yan; Yang Wang; Xuerui Mao
err分享
err收藏
Alkyl chain engineering of ionic AIE molecules for developing superior self-adjuvanted nanovaccines in cancer immunotherapy离子AIE分子的烷基链工程用于开发癌症免疫疗法中性能更优的自佐剂纳米疫苗
errCHEMICAL ENGINEERING JOURNAL
IF13.2
err2025-01-01
err0
errOAAI
errChen, Yijun; Bao, Yixuan; Wang, Yubo; Liu, Jiazhe; Zheng, Wenfang; Chen, Pu; Wei, Wei; Ji, Meiju; Zhang, Ruoyao; Hou, Peng; Chen, Chao
err分享
err收藏
Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide-Drug Conjugates通过设计新的PD-L1降解剂推进癌症免疫治疗: 从小分子到PD-L1-Specific肽-药物结合物的综合研究
errJOURNAL OF MEDICINAL CHEMISTRY
IF6.8
err2024-10-18
err0
errOAAI
errZeng, Zekun; Yang, Zhiwei; Li, Chenghao; Liu, Shujing; Wei, Wei; Zhou, Ye; Wang, Simeng; Sui, Mengjun; Li, Mengdan; Lin, Shumei; Cheng, Yangyang; Hou, Peng
err分享
err收藏
Engineering PD-L1 targeted liposomal canagliflozin achieves multimodal synergistic cancer therapy
errCHEMICAL ENGINEERING JOURNAL
IF13.2
err2024-10-01
err2
errOAAI
errWang, Simeng; Sui, Mengjun; Chen, Quan; Guo, Jiahua; Yang, Huini; Zhou, Ye; Ji, Meiju; Cheng, Yangyang; Hou, Peng
err分享
err收藏
BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer
errCELL DEATH & DISEASE
IF9.6
err2024-07-31
err1
errOAAI
errZhang, Jiahui; Liu, Xiaoli; Hou, Peng; Lv, Yang; Li, Gongfeng; Cao, Guozhen; Wang, Huogang; Lin, Wenchu
err分享
err收藏
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
errCELLULAR AND MOLECULAR LIFE SCIENCES
IF6.2
err2024-05-25
err0
errOAAI
errSui, Fang; Wang, Guanjie; Liu, Juan; Yuan, Mengmeng; Chen, Pu; Yao, Yao; Zhang, Shaoqiang; Ji, Meiju; Hou, Peng
err分享
err收藏
Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib
errENDOCRINE
IF2.9
err2024-04-02
err1
PREAI
errChen, Pu; Wang, Jianling; Yao, Yao; Qu, Yiping; Ji, Meiju; Hou, Peng
err分享
err收藏
High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade
errBMC CANCER
IF3.4
err2024-03-26
err2
errOAAI
errWang, Guanjie; Ren, Xiaojuan; Li, Jianying; Cui, Rongrong; Zhao, Xumin; Sui, Fang; Liu, Juan; Chen, Pu; Yang, Qi; Ji, Meiju; Hou, Peng; Gao, Ke; Qu, Yiping
err分享
err收藏
Smart multi-functional aggregates reoxygenate tumor microenvironment through a two-pronged strategy to revitalize cancer immunotherapy
errAGGREGATE
IF13.7
err2024-03-20
err2
errOAAI
errZhang, Yan; Liang, Luoqi; Li, Hexiang; Cao, Yuqing; Meng, Du; Li, Xinru; Wang, Meichen; Wang, Jingyuan; Yao, Yao; Zhang, Shaoqiang; Chen, Chao; Hou, Peng; Yang, Qi
err分享
err收藏
Pin1 inhibitor API-1 sensitizes BRAF-mutant thyroid cancers to BRAF inhibitors by attenuating HER3-mediated feedback activation of MAPK/ ERK and PI3K/AKT pathways
errINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
IF8.5
err2023-09-01
err5
PREAI
errDang, Hui; Sui, Mengjun; He, Qingyuan; Xie, Jingyi; Liu, Yan; Hou, Peng; Ji, Meiju
err分享
err收藏
A Feedback Loop Involving Exosomal miR-146a and NG2 to Propel the Development and Progression of Hypothyroidism
errTHYROID
IF6.7
err2023-08-16
err2
PREAI
errSui, Fang; Chen, Pu; Feng, Chao; Yang, Qi; Zhang, Shaoqiang; Ji, Meiju; Wang, Yinan; Guan, Haixia; Xing, Mingzhao; Hou, Peng
err分享
err收藏

研究方向

肿瘤遗传与表观遗传学肿瘤早期诊断与个体化治疗肿瘤分子靶向治疗个人及工作简历内分泌代谢转化医学细胞自噬与凋亡学术及科研成果、专利、论文BRAF突变在儿童急性淋巴细胞白血病中的功能致癌基因作用甲状腺癌中磷脂酰肌醇3-激酶/Akt通路的遗传改变及其关系基于微阵列的高通量单核苷酸多态性基因分型PRIMA-1恢复TP53突变型甲状腺癌细胞对组蛋白甲基化抑制剂3-脱氮胺苷酸敏感性遗传学改变在磷脂酰肌醇-3-激酶/Akt通路中的研究.jiaoshi{width:100%height:automargin-bottom:21px} .jiaoshi a{color:#0C58A4height:30pxline-height:30pxwidth:98%margin:0 autocolor:333font-size:14pxtext-align:lefttext-indent:21pxfont-family:"微软雅黑"!importantfont-weight:bold!important} .jstext{table-layout:fixedword-break: break-alloverflow:hiddenwidth:100%height:250px
合作学者
合作期刊
A
Adel K. El‐Naggar
H 指数: 132 · 论文数: 1.3K
王巍 封面图
王巍 (Wei Wang)
H 指数: 112 · 论文数: 2.6K
X
X. Peter
H 指数: 110 · 论文数: 315
H
Hugh S. Taylor
H 指数: 106 · 论文数: 1.1K
X
Xin‐Yuan Guan
H 指数: 99 · 论文数: 1.2K
查看更多